Biotechnology Stocks I Performance Guide: Cerevel Therapeutics Holdings, Inc. (CERE)
CERE has no dividends.
Table and Chart of CERE Performance
See what a $1,000 investment in CERE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CERE Returns | |
|---|---|
| Start Date | Nov-30-2020 |
| Start Price | $14.12 |
| End Date | Aug-01-2024 |
| End Price | $44.96 |
| # Prices | 46 |
| Min Date | Jan-29-2021 |
| Min Price | $12.87 |
| Max Date | Aug-01-2024 |
| Max Price | $44.96 |
| Total Return | 218.41% |
| Annualized Return | 35.27% |
| Current Value of $1,000 Purchase | $3,184 |
| Number Returns | 1,035 |
| Average Return | 44.78% |
| Number Profitable Returns | 758 |
| Percent Profitable Returns | 73.24% |
| Number Unprofitable Returns | 277 |
| Percent Unprofitable Returns | 26.76% |
| Profitable to Unprofitable Returns Ratio | 2.74 |
| CERE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -12.800 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -484523008 |
| PE to Growth Ratio | None |
| Price to Book | - |
| PRICE DATA | |
| 52 Week High | $1.407 |
| 52 Week Low | $44.99 |
| Analyst Target Price | $0 |
| 50-Day Moving Average | $19.59 |
| 200-Day Moving Average | $41.63 |
| FINANCIAL DATA | |
| Revenue per Share | $-2.73 |
| Revenue | $-1 |
| Profit Margin | 0% |
| Return on Equity | -29.8% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CERE Compare Returns with S&P 500
CERE Trendline Chart
CERE Moving Average Chart
CERE Stock Return Map - See Patterns of Gains and Losses
CERE Stock Returns/Purchase Dates